Raleigh drug maker’s ‘female Viagra’ could get FDA approval Tuesday

FILE - In this Friday, Sept. 27, 2013, file photo, a tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals in the company's Raleigh, N.C., headquarters. Government health experts on Thursday, June 4, 2015 backed the approval of the experimental drug intended to boost the female sex drive, but stress that it should carry safety restrictions to manage side effects including fatigue, low blood pressure and fainting. (AP Photo/Allen G. Breed, File)
FILE - In this Friday, Sept. 27, 2013, file photo, a tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals in the company's Raleigh, N.C., headquarters. Government health experts on Thursday, June 4, 2015 backed the approval of the experimental drug intended to boost the female sex drive, but stress that it should carry safety restrictions to manage side effects including fatigue, low blood pressure and fainting. (AP Photo/Allen G. Breed, File)

RALEIGH, N.C. (WNCN) – A Raleigh company’s pill that some are calling a female version of Viagra could be approved by the Food and Drug Administration as early as Tuesday.

The FDA is expected to rule Tuesday on the drug Flibanserin, which is made by the Raleigh-based company Sprout Pharmaceuticals.


CLICK TO SEE MORE PHOTOS OF SPROUT & THEIR “FEMALE VIAGRA”

If approved, it would become the first medication available to help improve the female libido.

In June, an FDA advisory panel recommended the drug be approved after failing FDA approval twice, first back in 2010.

There are critics who argue not much has changed since 2010 and that the drug’s effect on the libido is not clear and side effects such as sleepiness and dizziness are problematic.

The drug must be taken daily over a period of weeks to become effective.

Sprout Pharmaceuticals was featured as part of WNCN’s “What’s Next” series that focuses on local companies on the cutting edge of technology and ahead of trends.

MEDIA GENERAL may allow you to upload, post, transmit or otherwise provide content to MEDIA GENERAL Web sites, including, but not limited to, photos, video, audio, comments, articles, blogs, forums and any other such communication in which you provide content to the Web site ("User Content"). You agree that you are solely responsible for your communications and any content you provide. Read full terms and conditions of use by clicking here.

blog comments powered by Disqus